Picture of Mycelx Technologies logo

MYX Mycelx Technologies News Story

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsHighly SpeculativeMicro CapNeutral

REG - MyCelx Tech. Corp. MyCelx Tech. Cp-MYXR - Director/PDMR Shareholding

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220503:nRSC9828Ja&default-theme=true

RNS Number : 9828J  MyCelx Technologies Corporation  03 May 2022

2 May 2022

 

MYCELX Technologies Corporation

("MYCELX" or the "Company" (AIM: MYX)

 

 

Dealing by Director

 

The Company announces that it was notified on 2 May 2022 by Hal Alper,
President, Chief Science Officer and a Director of the Company, that on 10
November 2021 he sold 22,500 Common Shares at a price of £0.70 per Common
Share. Following this transaction, he continues to be interested in 1,219,546
Common Shares representing 5.31 per cent of the present issued capital of the
Company and in 124,339 options over the Company's Common Shares.

 

 

For further information please contact:

 

 MYCELX Technologies Corporation

 Connie Mixon, CEO                     Tel: +1 888 306 6843

 Kim Slayton, CFO

 Canaccord Genuity, Nominated Adviser

 Henry Fitzgerald-O'Connor             Tel: + 44 20 7523 8000

 Gordon Hamilton

 Celicourt

 Mark Antelme                          Tel: +44 20 8434 2754

 Jimmy Lea

 

Notification of transactions of persons discharging managerial responsibility
or connected persons

 

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Hal Alper

 2    Reason for the notification

 a)   Position/status                                              Director

 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         MYCELX Technologies Corporation

 b)   LEI                                                          213800UJZINIK2VD1G48

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument

                                                                   Common shares of US$0.025

      Identification code

                                                                   USU624551078

 b)   Nature of the transaction                                    Disposal of Common Shares

 c)   Price(s) and volume(s)

Price(s)  Volume(s)

                                                                   £0.70     22,500

 

 d)   Aggregated information

      - Aggregated volume                                          n/a

      - Price                                                      n/a

 e)   Date of the transaction                                      10/11/2021

 f)   Place of the transaction                                     London Stock Exchange

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

n/a

 

 

n/a

 

 

e)

 

Date of the transaction

 

 

10/11/2021

f)

 

Place of the transaction

 

 

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFFFEIELIFIIF

Recent news on Mycelx Technologies

See all news